Oncology and a year of COVID: lessons for the futureCOVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up Share XOncology and a year of COVID: lessons for the futurehttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/oncology-and-a-year-of-covid-lessons-for-the-future/
A year on: pandemic driven trends in HCP engagementIQVIA’s John Procter explores why the industry should be paying attention to the changing HCP customer experience in Share XA year on: pandemic driven trends in HCP engagementhttps://deep-dive.pharmaphorum.com/magazine/market-access-2021/a-year-on-pandemic-driven-trends-in-hcp-engagement-customer-experience/
Could a smartphone cough app stop future pandemics?A host of companies are looking at cough apps to detect the presence of COVID-19. But one company Share XCould a smartphone cough app stop future pandemics?https://pharmaphorum.com/views-and-analysis/could-a-cough-app-stop-future-pandemics/
The post-COVID face of pharma research and developmentThe acute phase of the COVID-19 pandemic not only brought delays, restrictions, and reconfigurations to pharmaceutical research & Share XThe post-COVID face of pharma research and developmenthttps://deep-dive.pharmaphorum.com/magazine/research-and-development-2021/telemedicine-remote-site-visits-post-covid-pharma-rd/
Healthcare’s digital transformation began within weeks of pandemic – reportHealthcare organisations that have been traditionally slow to adopt new technology produced a response to the pandemic that Share XHealthcare’s digital transformation began within weeks of pandemic – reporthttps://pharmaphorum.com/news/healthcares-digital-transformation-began-within-weeks-of-pandemic-report/
Novartis hails digital strategy as profits hold up during pandemicNovartis has said that its investment in digital technology has helped it to ride out the worst of Share XNovartis hails digital strategy as profits hold up during pandemichttps://pharmaphorum.com/news/novartis-hails-digital-strategy-as-profits-hold-up-during-pandemic/
Unlocking the potential in rare disease research with decentralised trialsA survey by rare disease patient network Raremark found that 86% of the community members asked were interested Share XUnlocking the potential in rare disease research with decentralised trialshttps://pharmaphorum.com/views-analysis-patients/unlocking-the-potential-in-rare-disease-research-with-decentralised-trials/
2021 – The healthcare changes here to stay2020 was the year that changed everything, and as the new year begins many are wondering what awaits Share X2021 – The healthcare changes here to stayhttps://pharmaphorum.com/views-analysis-digital/2021-healthcare-change/
2021 Outlook: The future for life sciences customer experienceResearch from a large-scale survey of 1000+ senior pharma professionals has highlighted the divide between digitally adept companies Share X2021 Outlook: The future for life sciences customer experiencehttps://pharmaphorum.com/views-analysis-sales-marketing/2021-outlook-the-future-for-life-sciences-customer-experience/
